3-Hydroxysterol Δ24-Reductase Promotes Ovarian Cancer Progression by Activating the TGF-1/Smad2/3 Signaling Pathway
Oncology Research · 2025
DOI: 10.32604/or.2025.065451 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Wenjing Liao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Transforming Growth Factor beta1, Oxidoreductases Acting on CH-CH Group Donors, Smad3 Protein. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
- Department of Radiology, Ping An Healthcare Diagnostics Center, Wuhan, 430014, China.
Zitieren
APA
Liao, W., Wang, L., Huang, Z., Zou, Z., Liu, Y., Liu, H., Duan, Z., & Tang, L. (2025). 3-Hydroxysterol Δ24-Reductase Promotes Ovarian Cancer Progression by Activating the TGF-1/Smad2/3 Signaling Pathway. Oncology Research. https://doi.org/10.32604/or.2025.065451
Vancouver
Liao W, Wang L, Huang Z, Zou Z, Liu Y, Liu H, et al. 3-Hydroxysterol Δ24-Reductase Promotes Ovarian Cancer Progression by Activating the TGF-1/Smad2/3 Signaling Pathway. Oncology Research. 2025. doi:10.32604/or.2025.065451
BibTeX
@article{Liao2025,
author = {Liao, Wenjing and Wang, Liaodi and Huang, Zhen and Zou, Ziyu and Liu, Yimin and Liu, Haoyue and Duan, Zhaoning and Tang, Liangdan},
title = {3-Hydroxysterol Δ24-Reductase Promotes Ovarian Cancer Progression by Activating the TGF-1/Smad2/3 Signaling Pathway},
journal = {Oncology Research},
year = {2025},
doi = {10.32604/or.2025.065451}
}
EUVIMED